Archives
- 2025-11
- 2025-10
- 2025-09
- 2025-03
- 2025-02
- 2025-01
- 2024-12
- 2024-11
- 2024-10
- 2024-09
- 2024-08
- 2024-07
- 2024-06
- 2024-05
- 2024-04
- 2024-03
- 2024-02
- 2024-01
- 2023-12
- 2023-11
- 2023-10
- 2023-09
- 2023-08
- 2023-07
- 2023-06
- 2023-05
- 2023-04
- 2023-03
- 2023-02
- 2023-01
- 2022-12
- 2022-11
- 2022-10
- 2022-09
- 2022-08
- 2022-07
- 2022-06
- 2022-05
- 2022-04
- 2022-03
- 2022-02
- 2022-01
- 2021-12
- 2021-11
- 2021-10
- 2021-09
- 2021-08
- 2021-07
- 2021-06
- 2021-05
- 2021-04
- 2021-03
- 2021-02
- 2021-01
- 2020-12
- 2020-11
- 2020-10
- 2020-09
- 2020-08
- 2020-07
- 2020-06
- 2020-05
- 2020-04
- 2020-03
- 2020-02
- 2020-01
- 2019-12
- 2019-11
- 2019-10
- 2019-09
- 2019-08
- 2019-07
- 2019-06
- 2019-05
- 2019-04
- 2018-11
- 2018-10
- 2018-07
-
Rucaparib (AG-014699): Precision Radiosensitization via P...
2025-09-28
Explore how Rucaparib (AG-014699, PF-01367338), a potent PARP1 inhibitor, enables precision radiosensitization in PTEN-deficient and ETS fusion-expressing prostate cancer cells. This article uniquely integrates RNA Pol II-dependent apoptotic signaling with advanced DNA damage response research.
-
Rucaparib (AG-014699): Beyond PARP Inhibition—Unraveling ...
2025-09-27
Explore how Rucaparib (AG-014699, PF-01367338), a potent PARP1 inhibitor, uniquely advances DNA damage response research by synergizing radiosensitization, synthetic lethality, and emerging apoptotic signaling. Discover its distinct applications in PTEN-deficient and ETS gene fusion-expressing cancer models.
-
Rucaparib (AG-014699): Systems-Level Insights into PARP1 ...
2025-09-26
Discover how Rucaparib (AG-014699, PF-01367338), a potent PARP inhibitor, is transforming DNA damage response research and cancer biology. This article uniquely explores systems-level synthetic lethality, advanced mechanistic pathways, and next-generation research applications.
-
Trichostatin A (TSA): Precision HDAC Inhibition for High-...
2025-09-25
Discover how Trichostatin A (TSA), a potent histone deacetylase inhibitor, enables precise epigenetic regulation in organoid and cancer research. This article uniquely explores TSA’s role in balancing self-renewal and differentiation, integrating new mechanistic insights and translational strategies for advanced epigenetic therapy.
-
EZ Cap™ EGFP mRNA (5-moUTP): Next-Gen Tools for Immunomod...
2025-09-24
Discover how EZ Cap EGFP mRNA 5-moUTP sets a new benchmark in mRNA delivery for gene expression, with deep insights into immune suppression, stability, and advanced in vivo imaging applications. This article provides a unique translational perspective linking molecular design to immuno-oncology innovation.
-
Tamoxifen in Translational Research: Pathways, Mechanisms...
2025-09-23
Tamoxifen, a selective estrogen receptor modulator, serves as a versatile molecular tool in cancer biology, antiviral studies, and gene knockout research. This article explores advanced mechanistic insights and practical considerations for Tamoxifen use, emphasizing its emerging roles in protein kinase C inhibition, autophagy, and translational model systems.
-
br Experimental br Acknowledgment br Introduction The NADPH
2025-03-03

Experimental Acknowledgment Introduction The NADPH-dependent reduction of d-glucose catalyzed by aldose reductase (E.C.1.1.1.21) (AR) is considered as one of the phenomena leading to the onset of long term diabetic complications [as review see: [1], [2]. In fact, the reduction of the sugar,
-
Additionally we were prompted to validate the
2025-03-03

Additionally, we were prompted to validate the protective effect of ALDH3A1 by utilizing a human corneal model. Cornea is located in the anterior segment of the eye and thus, is constantly exposed to various environmental stressors that affect the cellular oxidative balance and consequently lead to
-
Since natural and recombinant glycoprotein
2025-03-03

Since natural and recombinant glycoprotein hormones exhibit some differences in their carbohydrate structures, we checked whether this could affect the permissive effect on FSK-induced cyclic AMP response in MLTC-1 cells. Fig. 6 shows that the same sensitizing effect to FSK is observed with pituitar
-
Flavan-3-ol oligomer Ultraviolet UV spectroscopy is commonly
2025-03-03

Ultraviolet (UV) spectroscopy is commonly used for screening potential ADA inhibitors [15]. In the UV method, the ADA reaction is calculated by measuring the decrease in absorbance of the substrate at 265 nm or increase in absorbance of the product at 248 nm. However, AD and inosine share a very clo
-
TKI258 Our published data showed that in
2025-03-03

Our published data showed that, in mouse heart, the protein level of WDR1 was highest during the embryonic stage, but became progressively decreased to a constant level from birth to adulthood (Yuan et al., 2014), indicating an important role of WDR1 in embryonic heart development. However, function
-
In the present study the alternative
2025-03-03

In the present study, the alternative splicing of several nAChR subunits was identified in the oriental migratory locust (Locusta migratoria manilensis Meyen), a serious worldwide pest to agricultural production and also a model insect species [5]. Several α subunits were tried to co-express with ra
-
Finasteride has been shown to be a mechanism based
2025-03-03

Finasteride has been shown to be a mechanism-based inhibitor of 5AR-2 [9]. Finasteride acts as an alternate substrate for 5AR-2 and is initially bound in an extremely stable enzyme-bound NADP-dihydrofinasteride adduct which is ultimately processed to dihydrofinasteride. The NADP-dihydrofinasteride a
-
The observation that vortioxetine blocks
2025-03-03

The observation that vortioxetine blocks 5-HT-induced currents in 5-HT3 receptor-expressing oocytes suggests that vortioxetine acts to functionally antagonize these receptors, and is in line with previously published data (Bang-Andersen et al., 2011). For example, Mørk et al. (2012) demonstrated tha
-
The original Aurora kinase was identified during a phenotypi
2025-03-03

The original Aurora kinase was identified during a phenotypic screen for defects in mitotic spindles in Drosophila mutants. Aurora mutants were so named because of the morphological defects at the mitotic spindle resembling the Aurora borealis, or the Northern light [4]. The structure of the Auroras